256 Newsroom — Uganda's Digital News Infrastructure
Health

STAREE Trial: Atorvastatin Cuts Major CV Events by 30% in Older Adults, Driven Mainly by Nonfatal Events - Medscape

Published by Medscape By Becky McCall, MScPh, PhD, MSc · 29 August 2026 at 19:42
Share
STAREE Trial: Atorvastatin Cuts Major CV Events by 30% in Older Adults, Driven Mainly by Nonfatal Events - Medscape
Image · Medscape

What the report says

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Read the full report at Medscape →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Parliamentary Health Committee Flags Staffing, Equipment Gaps in Busoga HospitalsNile Post Rukungiri Health Workers Urged to Keep Professional Licences Up to DateNile Post Second Hospitality Skills Challenge Opens at HTTC in JinjaNile Post 256 Newsroom 2nd edition of hospitality skills challenge opens at Hotel and Tourism College - PML DailyPML Daily Health Experts Warn Against Late, Irregular And Missed Antenatal CareNile Post South Sudan, Uganda agree to ease cross-border activities during health emergenciesThe Independent Uganda